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Summary 
Using transgenic substrates, we found that the immu- 
noglobulin K gene B’enhancer (E33 acts as a negative 
regulator in V,-J. joining. Although the E3’ was origi- 
nally identified as a transcriptional enhancer, it acts in 
a suppressive manner for recombinational regulation. 
Base substitution analysis has shown that the PU.l- 
binding site within the E3’ regulates the B/T specificity 
of V.-J. joining. In a substrate with a mutated PU.l- 
binding site (GAGGAA to TCTTCG), V,-J. joining oc- 
curred not only in B cells, but also in T cells. The E3’ 
region is also responsible for determining the pro-61 
pre-B specificity of V.-J. joining. When the E3’ region 
was deleted, K gene rearrangement actively occurred 
at the early pro-B stage of B cell development: non- 
germline (N) nucleotides were common at recombina- 
tion junctions. 
Introduction 
V(D)J joining plays a key role in the activation and diversifi- 
cation of both immunoglobulin and T-cell receptor (TCR) 
genes (Yancopoulos and Alt, 1986). Joining is activated 
by recombination-activating genes (RAG7 and RAGP) 
(Schatz et al., 1989; Oettinger et al., 1990) and occurs 
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between two recombination signal sequences (RSSs) 
when one contains a 12 bp spacer and the other contains 
a 23 bp spacer (Akira et al., 1987). Although both immuno- 
globulin and TCR gene rearrangements follow this 12-23 
joining rule and utilize a common recombination machin- 
ery (Yancopoulos et al., 1986), V(D)J joining is regulated 
in a tissue-specific manner and in a time-ordered fashion 
(Alt et al., 1984; Reth et al., 1987). Complete immunoglob- 
ulin gene rearrangement occurs only in B cells, while TCR 
genes rearrange only in T cells. Although partial re- 
arrangement of the immunoglobulin heavy chain gene 
does occur in T cells, no light chain gene rearrangement 
is detected. In B cells, the heavy chain gene rearranges 
at the pro-B stage, while the light chain gene does so 
mainly at the pre-B stage (Maki et al., 1980). This time- 
ordered rearrangement used to be explained by the idea 
that functional production of the tr heavy chain might be 
a prerequisite to rearrangement of the light chain gene 
(Iglesias et al., 1991). However, this notion conflicts with 
the observation that K gene rearrangement occurs even 
in mutant mice with the Jr, locus deleted (Ehlich et al., 
1993). Therefore, the exact molecular mechanisms regu- 
lating the stage specificity of recombination are yet to be 
studied. 
It has been reported that the transcriptional enhancers 
located in the J-C introns of the heavy chain and K chain 
genes are essential for V(D)J joining (Serwe and Sablitzky, 
1993; Chen et al., 1993; Takeda et al., 1993). If the en- 
hancer regions are deleted, joining does not occur. This 
indicates that the J-C intron enhancers act as positive 
regulators in V(D)J joining, probably by making the joining 
regions accessible to the recombination machinery. A 
number of groups have made transgenic mice containing 
various joining substrates of different origin (Goodhardt 
et al., 1987; Ferrier et al., 1990; Lauster et al., 1993; re- 
viewed by Watrin et al., 1994). Curiously, many of the 
transgenes rearranged in both splenocytes and thymo- 
cytes: cell type-specific rearrangement was not repro- 
duced with these substrates. It is possible that the recom- 
bination substrates were not integrated into the proper 
chromosomal location required for tissue-specific control 
of V(D)J joining. An alternative explanation is that the 
transgenic substrates may have lacked a regulatory ele- 
ment that was necessary to halt unwanted rearrangement 
in inappropriate cell types. 
To study the tissue (B/T) specificity of rearrangement, 
we have looked for a &-acting DNA element that may 
antagonize the function of the intron enhancer that posi- 
tively regulates V,-J, joining. For the study of such sup- 
pressive elements, DNA transfer into cultured cell lines is 
not usually helpful. This is because theenhancer/promoter 
region of selectable markers (e.g., near) can affect the 
chromatin structure of the recombination substrate. For 
this reason, we have instead generated transgenic mice 
with various substrates for V,-J, joining. In this report, we 
present data showing that the region 8.4 kb downstream 
of the C, gene, i.e., the 3’ enhancer (E3’) region (Meyer 
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Table 1. V(D)J Joining in Various Transgenic Mice 
Transgenic Strain COPY Rearrangement Rearrangment 
Substrate Number Number” in T Cells in Pro-B Cells 
Figure I, Recombination Substrates Used in Our Transgenic Studies 
The substrate 3-r contains a germline V, segment, V,zI, (7 kb Hindlll- 
EcoRl fragment) (Heinrich et al., 1964) and the unrearranged J,-C, 
region (15 kb EcoRI-EcoRI fragment) (Sakano et al., 1979) of the 
BALBlc mouse. Other substrates contain various deletions in the re- 
gion downstream of C,. The coding regions of V, and C, are in boxes. 
Vertical bars are J, segments. Recombination signal sequences are 
indicated by triangles. Transcriptional enhancer elements (EK and E3’) 
are shown by open circles. Transcriptional promoters (P) are also 
shown. PCR primers used to detect rearrangement are indicated by 
arrowheads. The V, primer was 5’-AGCCAGTGAAAGTGTTGATAG-3’ 
(V,,, ]) or 5’.ATGCACTGGTACCAGCAGAAACC3’ (VQ,.~), and the Jhs 
primer was 5’-AGGTTGCCAGGAATGGCTCA-3’. Another primer, JK1 
(5’~CTCACTGAAGAGGAACAGAG-3’). was used to detect the unre- 
arranged V&-J, substrate. The horizontal bars represent the V, probe 
(Bglll-Bglll fragment) and the J, probe (Sphl-Pstl fragment) used for 
Southern blot hybridization. The 1.2 kb Xhol-EcoRI fragment contains 
all necessary sequences for the 3’ enhancer (E3’). which strongly in- 
creases lgk transcription. The core of E3’ can be divided into two 
subregions, a 126 bp Ncol-ApaLI fragment containing the PU.1 site 
and a 270 bp ApaLI-Xbal fragment containing the ISGF- and NF-EI- 
binding motifs. Three additional recombination substrates, generated 
from 3’-dE, have small deletions or base substitutions in the EB’subre- 
gions: dPUcontainsthe Ncol-ApaLI deletion, dNFcontainstheApaLI- 
Xbal deletion, and mPU.l contains a mutated sequence in the PU.l- 
binding site (GAGGAA changed to TCTTCG). 
and Neuberger, 1989) regulates not only the B/T specific- 
ity, but also the stage specificity of K gene rearrangement. 
Base substitution analysis has demonstrated that the 
PU.l-binding site in the E3’ is responsible for regulating 
the B/l specificity of V,-J, joining. 
Detection of Rearrangement in 
Transgenic Substrates 
Two types of recombination substrates were analyzed in 
the first set of experiments: the 3’-C, retained construct 
3’d 
3’-r 
3’-x 
3’-dE 
dPU 
dNF 
mPU1 
30 IO-15 
67 20-25 
79 20-25 
15 
45 
4 
2 
13 30-40 
16 15-20 
a IO 
11 2 
12 to-15 
14 6 
17 10-15 
3 IO-15 
5 2 
6 IO-15 
10 a 
5 a 
20 1 o-5 
34 6 
9 5-10 
13 l-3 
20 1 O-20 
26 5-10 
+ + 
+ + 
+ NDb 
- - 
- -c 
+ + 
+ ND 
- + 
- ND 
- += 
- ND 
- ND 
+ ND 
+ ND 
+ ND 
+ ND 
- ND 
- ND 
- ND 
+ ND 
ND ND 
+ ND 
ND ND 
a The copy number was quantified with Fj mice, except that Fa mice 
were used for mPU1. 
D ND, not determined. 
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(3-r) and the 3-C deleted construct (3’-d) (Figure 1). Both 
constructs contain a 7 kb fragment (Hindill-EcoRI) of the 
mouse VKZIc germline segment. The 3’-r construct carries 
a 15 kb EcoRl fragment containing the J,-C, region and 
the 3’ enhancer (E3’) (Meyer and Neuberger, 1989). In 
contrast, 3’-d carries the same J,-C, region, but its 3’ por- 
tion containing E3’has been deleted at the Hpal site in the 
middle of C,. We analyzed three independent transgenic 
founders for 3’-d and two for 3’-r (Table 1). For each 
transgenic mouse, DNA was extracted from various tis- 
sues, and V,-J, joining was detected by polymerase chain 
reaction (PCR) and Southern blot hybridization. 
To detect DNA rearrangement in the transgenic sub- 
strates, we synthesized PCR primers: one corresponded 
to the VrPlc gene segment, and the other corresponded 
to the region upstream of JKs (Figure 1). To detect the 
unrearranged substrate, we made another primer in the 
region upstream of J,,. After PCR amplification, the V,-J, 
region was analyzed for DNA rearrangement by Southern 
blot hybridization using the V r21C region (1.6 kb Bglll-Bglll 
fragment) as a probe (Figure 2). A band of 2.4 kb represent- 
ing an unrearranged structure was detected in all DNA 
samples tested in our study. Three additional bands were 
detected in spleen and some thymic samples. They mea- 
sured 1.3 kb, 0.98 kb, and 0.35 kb, corresponding to the 
rearranged structures of VrPIC-Jr,, Vr21C-JrZ, and VrZIC-Jrl. 
respectively. No Vr21c-Jr3 rearranged structure was ob- 
served, since JliJ is a pseudogene and cannot rearrange. 
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Figure 2. Detection of V,-J, Joining in the Transgenic Substrates 
Two independent transgenic lines were analyzed for each substrate. 
DNA rearrangement was studied in the thymus (T). spleen (S), and 
kidney(K). To detect DNA rearrangements, theV.-J, region was ampli- 
fied from the substrates by PCR using the primers shown in Figure 
1 as described in the Experimental Procedures. PCR products were 
separated in an agarose gel and detected by Southern blotting using 
the V. probe (see Figure 1). For 3,-r, twice the sample volume was 
applied to the gel, because the copy number of 3’.r was lower than 
that of 3-d. The three bands of 1.3 kb, 0.98 kb, and 0.35 kb represent 
the structures of V,-J,,, V,-J,,, and V,-J,, rearrangements, respec- 
tively. 
Under the PCR conditions used in this experiment, no 
bands were seen in samples from nontransgenic mice. 
This indicates that VnPlc-Jn rearrangements in the endoge- 
nous (nontransgene) alleles did not contribute to the hy- 
bridization shown in Figure 2. 
BIT Specificity in V.-J, Joining 
When we compared the hybridization patterns of the two 
substrates (3’-d and 3’-r), we noticed a striking difference 
in the tissue specificity of rearrangement (Figure 2). With 
3-d, rearrangement occurred in both the spleen and the 
thymus in all three transgenic lines tested in our study. 
This indicated that V,-J, joining occurred even in T cells 
when the region downstream of C, was deleted. In con- 
trast, with 3’-r, the spleen DNA contained rearrangements, 
but thymus DNA was unrearranged in both founders, num- 
ber 15 and number 45. No rearrangement was seen in 
nonlymphatic tissues (e.g., kidney, liver, and brain) in ei- 
ther 3’-r or 3’-d. These results indicated that V,-J, joining 
was restricted to B cells in 3-r, but not in 3-d. To confirm 
this notion further, we isolated B cells and T cells from 
splenocytes with anti-B220 antibodies and anti-Thyl.2 an- 
tibodies by use of a fluorescence-activated cell sorter 
(FACS). DNA was then isolated from the FACS-sorted cells 
and analyzed for V,-J, joining by PC&Southern blot hy- 
bridization. As shown in Figure 3, the B/T specificity of V,- 
J, joining was regulated normally in 3’-r, butderegulated in 
3’-d. Since the only difference between the two substrates 
was in the region downstream of C, (see Figure l), it 
seemed that this region must contain a DNA element that 
prevents K gene rearrangement in T cells. 
We should keep in mind the possible effect of transgene 
copy number on the control of gene rearrangement..lt is 
possible that a limited number of repressor-like molecules 
are responsible forthe negative regulation of V,-J,joining. 
If so, an excess number of transgenic substrates may 
sweep out all the repressor molecules, thus deregulating 
the cell type specificity of recombination. If this type of 
deregulation is actually happening in some transgenic 
3’-d T-r T-X 3’dE 
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Figure 3. Detection of V&-J, Joining in Purified B Cells and T Cells 
We analyzed DNA rearrangement in four transgenic substrates, 3’-d 
(number 30) 3’.r (number 15) 3-x (number 19) and 3’.dE (number 8). 
Splenocytes were sorted with FACS using anti-B220 or anti-Thyl.2 anti- 
bodies DNA was purified from the sorted cells, amplified by PCR, and 
analyzed by Southern blot hybridization as described in Figure 2. 
mice, then the endogenous (nontransgenic) K gene must 
also be rearranging in T cells. To test this possibility, we 
have analyzed the endogenous Vn4, gene. To detect en- 
dogenousgene rearrangement, the number of PCR cycles 
was increased from 21 to 28. In the 3-d (number 30) 
transgenic mouse, the Vr4, gene was rearranged in FACS- 
sorted B cells (8220’) but not in T cells (Thyl.2+) (Figure 
4), indicating that the Bfrspecificityof endogenousjoining 
was not deregulated. The same result was obtained from 
another founder (number 67) with the 3’-d substrate. Thus, 
the deregulation of recombination observed in the3’-d sub- 
strate is not attributable to the transgene copy number. 
nonTG 3’-r Z-d 
~ - - 
TBK T B K T B K 
Figure 4. Detection of Endogenous J, Rearrangements 
Using a VX4, sequence as a PCR primer, we analyzed endogenous 
J, rearrangements. DNA was isolated from Thyl.2’ splenocytes (T), 
822O’splenocytes (B). and kidney cells(K) of nontransgenic (non TG), 
3’-r (number 15) transgenic, and 3’-d (number 30) transgenic mice. 
The rearranged J, region was amplified with V,,, (5’-GACATT- 
GGTAGTAGCTTAAAC3’) and Jxs primers. To detect the endogenous 
genes, we increased the number of PCR cycles from 21 to 28. PCR 
products were separated in an agarose gel and detected by Southern 
blot hybridization with the J, probe (see Figure 1). Unrearranged 
structures are not detected, because the V,,, and J, regions are far 
apart in the endogenous gene. 
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The 3’ Enhancer Region Contains 
the Suppressive Element 
To narrow down the location of the suppressive element, 
we generated smaller deletions in the region downstream 
of C,. Since the E3’ region had been reported to have 
nuclear protein-binding sites necessary to regulate tran- 
scription (Meyer and Neuberger, 1989; Pongubala and At- 
chison, 1991; Pongubala and Atchison, 1995) we deleted 
the E3’region first. With the Xhol enzyme we could conve- 
niently remove the entire E3’ region from 3’-r, generating 
a new substrate, 3’-x. The only difference between these 
two substrates is that 3(-x is shorter than 3’-r by 1.2 kb at 
the 3’ end (see Figure 1). 
We analyzed the B/T specificity of 3’-x rearrangement 
in two independent founders, number 13 and number 18 
(Table 1). DNA was isolated from FACS-sorted splenic B 
cells (B220’) or T cells (Thy 1.2+) and analyzed by Southern 
blot hybridization after PCR amplification. As shown in 
Figure 3, both B cells and T cells contained V,-J, re- 
arrangements in the 3-x transgene. Both transgenic 
founders (number 13 and number 18) gave the same re- 
sults. These observations indicate that the suppressive 
element regulating the B/T specificity of K gene re- 
arrangement resides within the E3’ region of 1.2 kb. 
BIT Specificity Can Be Restored by Adding the E3’ 
Region to 3’-d 
We then studied whether the B/T specificity of V,-J, join- 
ing could be restored to the 3’-d substrate by adding back 
the E3’ region. This experiment also tests whether the 
E3’ region needs to cooperate with some other elements 
residing between C, and E3’. To examine this possibility, 
we constructed a new transgenic substrate, 3’-dE, by ligat- 
ing the 1.2 kb E3’ fragment (Xhol-EcoRl) to the 3’ end of 
the 3’-d substrate (see Figure 1). Five independent found- 
ers were obtained and analyzed (see Table 1). In all found- 
ers, the BIT specificity of V,-J, joining was restored in the 
new substrate 3’-dE, suggesting that the E3’ region by 
itself was able to add the B/T specificity back to the former 
substrate 3’-d (see Figure 3). 
An E3’ Subregion Covering the PU.l-Binding Site 
Contains the Suppressive Element 
To narrow down further the regulatory element in E3’, we 
generated two small deletions in the substrate 3’-dE: one 
construct (dPU) had a 128 bp deletion covering the PU.l- 
binding site (Pongubala et al., 1992) and the other con- 
struct (dNF) had a 270 bp deletion covering the NF-El 
site (Park and Atchison, 1991) and an ISGF motif (see 
Figure 1). Four dPU and three dNF transgenic lines were 
produced and analyzed (see Table 1). As shown in Figure 
5, the dPU mouse (number 6) had transgene re- 
arrangements in both FACS-sorted B cells and T cells. In 
contrast, the dNF construct (founder number 20) under- 
went very little rearrangement in T cells, but rearranged 
at high levels in B cells. The same results were obtained 
from other independent founders (see Table 1). These re- 
sults show that the E3’ subregion of 128 bp (Ncol-ApaLl) 
that includes the PU.l-binding site (see Figure 1) contains 
3’-dE dPU dNF 
TBTBTB 
dpu w --------- *w 
Figure 5. V&-J, Joining in Transgenic Substrates Containing Dele- 
tions in the 3’ Enhancer 
We analyzed the B/T specificity of DNA rearrangement in three 
transgenic substrates: 3’-dE (number 12) dPU (number 6) and dNF 
(number 20). T cells (T) and B cells (6) were purified from splenocytes 
by FACS sorting with anti-9220 and anti-Thyl.2 antibodies. DNA was 
amplified by PCR and analyzed as described in Figure 2. 
the &-acting suppressive element that regulates the 
B/T specificity of V,-J, joining. 
The PU.l-Binding Site Itself Determines the B/T 
Specificity of V.-J. Joining 
Since a 128 bp DNA deletion covering the PU.l-binding 
site resulted in the loss of the B/T specificity, we created 
a new transgenic construct, mPU1, which contains a mu- 
tated sequence (GAGGAA to TCTTCG) for the PU.l- 
binding site in 3’dE (see Figure 1). We obtained four F0 
transgenic mice carrying the mPU1 substrate, two of 
which (number 9 and number 20) have now been analyzed 
(see Table 1). Our studies indicate that the PU.l-binding 
site itself regulates the BIT specificity of V,-J, joining (Fig- 
ure 6). DNA isolated from mPU1 thymocytes (treated with 
anti-IgG antibodies to remove residual B cells) had un- 
dergone V,-J, joining in both founders, while no re- 
arrangement was seen in the 3’-dE thymocytes where the 
PU.l site was not mutated. 
Stage-Specific Recombination 
In the endogenous K genes, V,-J, joining normally occurs 
at the pre-B stage of B cell development. To study at what 
stage(s) joining occurs in the transgenic substrates, we 
fractionated B220+ bone marrow cells into six different 
subpopulations by FACS. According to Hardyet al. (1991) 
8220’ cells can be sorted into six developmental stages 
(prepro-B, early pro-B, late pro-B, pre-B, immature B, and 
mature B) on the basis of the expression of five different 
cell surface markers: CD43, HSA, BP-l, IgM, and IgD (Fig- 
ure 7). After sorting B-lineage cells according to this 
scheme, we purified DNA and analyzed it for re- 
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Figure 6. V&-J, Joining in the PU.l-Mutated Substrate 
The PU.l -binding sequence in E3’ was mutated from GAGGAA to 
TCTTCG, and the mutant sequence was introduced into the 3’dE 
construct. The transgenic founder with the mutant substrate mPU1 
(number 9) or the 3’-dE substrate (number 8) was analyzed. DNA sam- 
ples from kidney(K), spleen (S), and thymus (T) were studied by PCR- 
Southern blot as described in Figure 2. Thymocytes were treated with 
anti-mouse IgG (H plus L) antibodies to remove contaminating B cells. 
arrangement (Figure 8). Rearranged bands in the 3’-r 
(number 45) substrate were detected in pre-B, immature 
B, and mature B cells. A faint band of J,, rearrangement 
was also seen at the late pro-B stage. For this experiment, 
we carried out Southern blot hybridization with the J, probe 
under high stringency conditions to avoid nonspecific hy- 
bridization. Therefore, V,-JKI rearrangements appeared 
as faint bands, because they shared only a small region 
of overlap with the probe. As a control, rearrangement of 
the endogenous K gene was examined with the Vn4, 
primer. Endogenous rearrangement is initiated in the K 
gene in the 3’-r (number 45) mouse at the same stage as 
in the transgene (Figure 8): a low level of rearrangement 
was seen at the late pro-B stage, and rearranged bands 
were detected strongly at the pre-B and the later stages. 
A similar pattern of K gene rearrangement was detected 
in nontransgenic mice (Li et al., 1993). When the substrate 
3’-d (number 30) was used, high levels of rearrangement 
of the transgene were found even in early pro-B and late 
pro-B cells. Weak J,, rearrangement was seen also in pre- 
pro-B cells, indicating that the rearrangement of 3’-d 
started to occur soon after the RAG genes were activated 
(Hardy et al., 1991). It should be noted that rearrangement 
of the endogenous K gene is not occurring in the 3’-d 
mouse until the late pro-B stage (data not shown). Since 
the stage specificity of endogenous rearrangement ap- 
pears to be normal in the transgenic mouse, the deregula- 
tion of rearrangement in the 3’-d transgenic substrate is 
Endogenous 
K gene 
d unrearranged 
+ VKZIC-JXI 
4 vme-JKZ 
E3’ 
* 
Figure 8. Detection of V,-J, Joining at Various Stages of B Cell Devel- 
opment 
Bone marrow cells from 3-r (number 45) and 3-d (number 30) 
transgenic mice were separated by FACS into six different develop- 
mental stages as described in Figure 7. We analyzed V,-J, joining in 
the transgenic substrates by using 26 cycles of PCR, and joining in 
the endogenous K gene was detected with the V,,, primer after 30 
cycles of amplification. PCR products were separated in an agarose 
gel and detected by Southern blotting with the J, probe (see Figure 
1). Note that in the endogenous K gene from the 3-r (number 45) 
mouse, major rearranged bands are found only after the late pro-B 
stage. The same result was found for the endogenous K gene in the 
3’.d mouse. 
not due to the copy number effect as already discussed 
for B/T specificity. We have analyzed two independent 
founders for 3’-d (number 30 and number 67) and detected 
the same deregulated pattern of rearrangement. For this 
reason, we assume that the deregulation observed in the 
transgene is not caused by integration into a specific site 
in the chromosome. We therefore conclude that the region 
downstream of C, is important not only for the BITspecific- 
ity, but also for the stage specificity of V,-J, joining. 
cD43+ CD43+ 
HSA - HSA + 
BP-l - BP-l - 
cD43+ 
HSA + 
BP-l + 
cD43- CD43- CD43- 
IgM - IgM+ IgM+ 
IgD - IgD - IgD + 
DH-JH VH-DHJH VK-JK 
joining joining joining 
- TdT+ - - TdT- - 
Figure 7. Classification of B-Lineage Cells 
8220’ bone marrow cells can be subdivided 
into six different developmental stages (pre- 
pro-B. early pro-B. late pro-B, pre-B, immature 
B, and mature B), on the basis of the expres- 
sion patterns of five cell surface markers: 
CD43, HSA, BP-l, IgM, and IgD (Hardy et al., 
1991). Normally, V&-J, joining occurs mainly 
at the pre-B stage of E3 cell development, while 
the heavy chain rearrangements take place at 
the pro-B stages. TdT activity, responsible for 
N-nucleotide addition, is present in pro-6 cells, 
but low or absent in pre-B cells. 
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Nongermline Nucleotides at V.-J. Junctions 
To study the stage specificity of rearrangement with a dif- 
ferent approach, we have analyzed the sequences of the 
V,-J, junctions. In the endogenous immunoglobulin 
genes, nucleotide addition is common in the heavy chain 
gene, but far less frequent in the K light chain gene. Termi- 
nal deoxynucleotidyl transferase (TdT) is responsible for 
adding the nongermline (N) nucleotides (Alt and Baltimore, 
1982; Komori et al., 1993; Gilfillan et al., 1993). TdTactivity 
is high in pro-8 (p-, B220+) cells, but low in pre-B (u+, 
B220+) cells (Landau et al., 1987; Li et al., 1993). Since 
K gene rearrangement occurs mainly at the pre-B stage, 
N nucleotide addition is rare in the endogenous K gene. 
We separated 8220’ bone marrow cells from 3’-d and 
3’-r transgenic mice into p+ and pm subpopulations; we 
then analyzed rearrangements by Southern blotting. In 
both substrates, 3’-d and 3’-r, three rearranged bands (1.3, 
0.98, and 0.35 kb corresponding to J,,, JrP, and Jr4 re- 
arrangements, respectively) were detected in p+ cells 
(data not shown). When substrate 3’-d was used, re- 
arrangements were found also in pL cells, while very little 
rearrangement was found in pm cells with substrate 3’-r. 
In all the transgenic samples, a 2.4 kb unrearranged struc- 
ture was detected. 
When we analyzed the 3’-d transgene isolated from ~-1 
B220+ bone marrow cells, 27 joints out of 32 contained N 
nucleotides. In two cases, as many as seven nucleotides 
were inserted at the joint (Figure 9a). It is likely that re- 
arrangement occurred in 3’-d when TdT activity was high, 
i.e., at the pro-B stage. With the same substrate, when p+ 
cells were analyzed (Figure 9b), the frequency of nucleo- 
tide insertion was a little lower (17 of 32) indicating that 
joining continued to occur in the pre-B (TdT-) stage of B 
cell development. 
In contrast, the 3-r substrate isolated from ~‘18220’ 
cells contained very little nucleotide addition. The majority 
(270f 30) of the joints did not contain any extra nucleotides 
at all (Figure SC), and a few (3 of 30) contained just one 
N nucleotide. This observation indicates that the 3’-r sub- 
strate underwent V,-J, joining when TdT activity was low 
or absent, mainly at the pre-B stage of B cell development. 
These findings further support our conclusion that 3’-d 
rearranges in both pro-B and preB cells, while 3’-r under- 
goes joining mainly in pre-B cells. 
The E3’ Region Regulates the Stage Specificity 
of V.-J. Joining 
The experiments described above show that the stage 
(pro-Blpre-B) specificity of V,-J, joining is regulated by a 
c&acting element(s) contained somewhere within the 9.6 
kb region downstream of C,. Since the E3’ region was 
responsible for B/T specificity, it may determine the pro-B/ 
pre-B specificity as well. To test this possibility, we ana- 
lyzed the pro-Blpre-B specificity of DNA rearrangement 
in the 3-x (number 13) substrate. B220+ bone marrow ceils 
were isolated from the transgenic mice and sorted by 
FACS into six subpopulations as described above. As 
shown in Figure 10, V,-J, joining was detected strongly 
in early pro-B cells. This indicated that the 1.2 kb EB’region 
contained a regulatory element for the pro-Blpre-B speci- 
ficity of K gene rearrangement. lt is not yet clear whether 
the same element responsible for B/T specificity also de- 
termines the pro-Blpre-B specificity of V,-J, joining. 
B/T specificity of joining was restored in 3’-dE when the 
E3’ region (1.2 kb Xhol-EcoRI fragment) was added back 
to the 3’ end of the 3’-d substrate. We tested whether this 
would also be true for pro-Blpre-B specificity. Bone mar- 
row cells from the 3’-dE (number 8) mice were fractionated 
and analyzed for V,-J, joining in the transgenic substrate. 
Unlike BIT specificity, the pro-Blpre-B specificity was not 
a 3-d (p-/B22o+ccus) 
“tizlc N 
b 3’4 ( ~++w220+ cells ) C 3-r (p+/B220+ cells ) 
VrZlC N Jr YKZLC N Jr; 
Figure 9. Nucleotide Sequences at the V,-J, Junction in Transgenic Substrates 
Bone marrow cells were isolated from 3’-d (number 30) or 3’-r (number 45) transgenic mice. 8220’ cells were subdivided into p+ and pm by FACS 
sorting. DNA was isolated from the cells, subjected to PCR amplification, and separated in an agarose gel. Rearranged structures were extracted 
from the gel, cloned, and sequenced. About thirty junctional sequences (V .zl,-J.) were determined for each cell type: ~-18220’ cells with substrate 
3’-d (a), t1’1B220’ cells with substrate 3’-d (b), or p’lB220’ cells with substrate 3-r (c). Nongermline (N) nucleotides at the junction are shown in 
lowercase letters. 
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c3unrearranged 
- VKZIC-JKI 
- VKZIC-JKZ 
U unrearranged 
a VIUICJKI 
- Vmc-JKZ 
3’-dE 
-Uunrearranged 
4 VKZIC-JKI 
-*+ M VKZIC-JKZ 
3’-dE,-e-... ___. c(k 
Figure 10. Stage Specificity of V,-J, Joining in 3’-x and 3’.dE Mice 
Bone marrow cells were isolated from 3’-r (number 45), 3’-x (number 
13), and 3’-dE (number 8) transgenic mice and fractionated into six 
different populations as described in Figure 7. DNA was purified from 
the sorted cells, amplified by PCR, and analyzed by Southern blot 
hybridization as described in Figure 8. 
fully restored in 3’-dE (Figure 10): V,-J,joining was already 
detected in early pro-B cells. Another founder (number 12) 
also showed transgene rearrangement in pro-B cells. As 
in the 3’-r and 3’-d mice, the endogenous K gene in the 
3’-dE mouse did not begin rearranging until the late pro-B 
stage (data not shown). These observations indicate that 
the E3’ region contains a suppressive element regulating 
the pro-Blpre-B specificity, but may need to cooperate with 
another element which is yet to be found somewhere be- 
tween C, and E3’. 
Discussion 
The 3’ Enhancer Negatively Regulates V.-J, Joining 
We have demonstrated that the E3’ region contains DNA 
element(s) necessary to achieve the tissue (B/T) specificity 
and stage (pro-Blpre-B) specificity of K gene recombina- 
tion. When the E3’ region was deleted, V,-J, joining oc- 
curred not only in B cells, but also in T cells. Even in B 
cells, K gene rearrangement started at the early pro-B 
stage. In contrast, the transgenic substrate with the 9.6 
kb region downstream of C, containing E3’ underwent re- 
arrangement only in B cells, mainly at the pre-B stage. 
These experiments suggest that the E3’ region contains 
a suppressive element(s) that restricts K gene re- 
arrangement to the pre-B stage of B cell development. 
It is interesting that an 8.4 kb deletion between C, and 
E3’ did not affect the B/T specificity at all. However, the 
same deletion significantly lowered the pro-Blpre-B speci- 
ficity of V,-J, joining. This observation may indicate that 
an additional cis-acting element, required to achieve the 
stage specificity of V,-J, joining, resides somewhere be- 
tween C, and E3’. In this regard, Matthias and Baltimore 
(1993) have discovered another transcriptional regulatory 
region (second 3’ enhancer) between the Ca gene and 
E3’in the immunoglobulin heavy chain gene. It is possible 
that a similar DNA element exists in the K light chain gene 
system and helps to control the stage specificity of V,-J, 
joining. 
Possible Roles of the PU.l-Binding Site 
in the Control of V,-J, Joining 
Our recent results indicate that the PU.l-binding site is 
responsible for the B/l specificity of K gene recombina- 
tion. It is unlikely, however, that the PU.l protein itself acts 
as a recombinational repressor. First, the PU.l protein, in 
association with NF-EM5, works in a positive manner in 
regulating light chain gene transcription (Pongubalaet al., 
1992; Eisenbeis et al., 1993), although there is at least one 
report suggesting that PU.l may act as a transcriptional 
repressor (Ross et al., 1994). Second, whatever factor(s) 
inhibit K gene recombination must be present or active in 
Tcellsor pro-B cells but not in pre-B cells. The PU.1 protein 
is reported to be present in B cells but not in any T cell 
lineexamined (Klemszet al., 1990; Pongubalaetal., 1992; 
Hromas et al., 1993), although Scott et al. (1994) demon- 
strated a lack of T cells in PU.1 knockout mice, suggesting 
that PU.l may have a role in early T cell development. In 
terms of stage specificity, the PU.1 protein is present at 
both the pro-B and the pre-B stages. Thus, it is doubtful 
that the PU.l protein itself is a direct regulator of either 
the stage specificity or the B/T specificity of V,-J, joining, 
although phosphorylation of the PU.l protein may still be 
responsible for regulating stage specificity (Pongubala et 
al., 1993). It seems more likely, however, that a novel pro- 
tein, perhaps another ETS family member, acts as the 
repressor of K gene recombination. 
Alternatively, a novel inhibitory factor(s) may suppress 
recombination by competing with PU.l or NF-EM5 Such 
an inhibitory factor could block the function of PU.l and 
keep the chromatin structure inaccessible to the recombi- 
nase. In this regard, Eisenbeis et al. (1995) have recently 
isolated the pip gene (for PU.l interaction partner), which 
very likely encodes the NF-EM5 protein. They found that 
the pip gene has a high sequence identity with the gene 
coding for the transcription factor ICSBP (for interferon 
consensus sequence-binding protein) (Driggers et al., 
1990), which also interacts with PU.l. Since ICSBP antag- 
onizes activation by IRF-1 (interferon regulatory factor 1) 
and ISGFB (interferon-stimulated gene factor 3), Eisenbeis 
et al. (1995) suggest that ICSBP may be a negative regula- 
tor of the Igh enhancer and the K E3’: ICSBP may interfere 
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with the function of PU.l by competing with PIPINF-EM5 
for binding to the PU.l protein. 
Transcriptional Enhancers and V(D)J Recombination 
Transgenic and knockout studies have demonstrated that 
the intron enhancer region also plays important roles in 
the control of V(D)J recombination. For example, removal 
of the IgH intron enhancer resulted in loss of D-J joining 
in the IgH locus (Serwe and Sablitzky, 1993; Chen et al., 
1993). Similarly, homozygous mutant mice lacking the IgK 
intron enhancer exhibited no V,-J, joining (Takeda et al., 
1993). Transgenic experiments using TCRa or TCRP gene 
substrates implied that TCR enhancers act to induce and 
restrict the recombination to T cells (Capone et al., 1993). 
These experiments and our present study suggest that 
enhancer regions, originally identified as transcriptional 
regulators, also regulate V(D)J recombination in both posi- 
tive and negative manners. 
It has been reported that low level transcription usually 
precedes rearrangement both in V(D)J joining and class 
switch recombination (Yancopoulos and Alt, 1986). Fur- 
thermore, the induction of immunoglobulin gene transcrip- 
tion accelerates recombination (Schlissel and Baltimore, 
1989). This has led to a model proposing that transcription 
is a prerequisite for recombination and to another model 
proposing that both transcription and recombination are 
secondary to what has been termed opening of the chro- 
matin structure. It is not easy to distinguish experimentally 
between these two possibilities (Engler et al., 1991; Hsieh 
et al., 1992), especially when regulatory elements for re- 
combination are associated with those for transcription. 
It is interesting to note that while the K intron enhancer 
serves as a positive regulator of both transcription and 
recombination, the E3’ region is a positive regulator of 
transcription but a negative regulator of recombination. 
If transcriptional enhancers and silencers are indeed 
regulators of recombination, the physical basis for this 
control by enhancers is as yet unclear. One possibility 
is that enhancers control recombination by determining 
accessibility of the substrate DNA, i.e., by altering chroma- 
tin structure. The role of silencers in transcriptional control 
has been studied in detail in mating-type genes in yeast 
(Laurenson and Rine, 1992), where silencer-binding pro- 
teins were found to interact directly with histones, leading 
to an inaccessible chromatin structure (Moretti et al., 1994; 
Hecht et al., 1995). Silencing found in V,-J, joining may 
occur by a similar mechanism. 
Recombination, Transcription, and Methylation 
As discussed above, the transcriptional activity of a gene 
may affect its ability to rearrange. We therefore examined 
the transcriptional activity of the transgenic substrates in 
our mice by Northern blotting of RNA isolated from thymus, 
spleen, or kidney (Ft. H., unpublished data). Transcripts 
of the 3’d and 3’dE substrates were not detectable in 
kidney. In spleen, both substrates were transcribed, but 
the 3’-dE transcripts were present at a higher level, pre- 
sumably owing to the influence of the E3’on transcription. 
Transcripts of 3’-d, but not 3”dE, were present in thymus. 
However, this result is difficult to interpret. It may indicate 
that a transcriptional silencer, present in the 3’-dE con- 
struct, is missing from 3’-d. On the other hand, DNA re- 
arrangement, which occurs in 3’-d but not in 3’-dE, may 
result in activation of transcription by bringing the intron 
enhancer closer to the promoter. 
To address properly the question of whether transcrip- 
tion is a prerequisite for recombination, we would have to 
analyze the low level of germline transcription that usually 
precedes rearrangement. Unfortunately, we were unable 
to detect these germline transcripts, because we cannot 
obtain enough RNA from sorted cells of transgenic mice. 
DNA methylation of the cytosine residue within the dinu- 
cleotide CpG also plays a role in the regulation of tissue- 
specific gene expression (Bird, 1992) and recombination 
(Hsieh and Lieber, 1992; Engleret al., 1993). Specific CpG 
residues within the J, locus are demethylated in 6 and 
plasma cells, and the K gene intron enhancer plays a role 
in inducing demethylation in the J, locus (Storb and Arp, 
1983; Lichtenstein et al., 1994). The enhancer-mediated 
methylation status of the DNA may regulate transcription 
and recombination directly or indirectly via changes in 
DNA topology. Therefore, we have analyzed the methyla- 
tion status of the transgenic J, locus in our mice (R. H., 
unpublished data). Methylation of the 3’-r substrate was 
regulated in a tissue-specific manner: the J, locus was 
demethylated only in spleen cells, not in thymus, kidney 
or liver. In contrast, demethylation of the J, locus in 3’-d, 
3’-x, and 3’-dE substrates occurred in all of these tissues. 
These results suggest that the E3’ region is necessary but 
not sufficient for proper regulation of the methylation in the 
J, locus. Furthermore, J, methylation status is not involved 
directly in the B/l specificity of V,-J, joining, since in T 
cells the 3’-dE substrate is demethylated but still does not 
undergo recombination. Apparently the accessibility of 
DNA to the V(D)J recombinase is not determined directly 
by its methylation status. 
In the present study, we have identified a recombination- 
suppressive element in the E3’ region of the K gene. Be- 
cause DNA transfer into cultured cell lines is not useful 
for the study of such negative regulators, transgenic mice 
were generated and analyzed throughout the study. Al- 
though this approach was extremely time-consuming, we 
have now concluded that the PU.l-binding sitedetermines 
the BIT specificity of V,-J, joining. The E3’ region also 
regulates the stage (pro-Blpre-B) specificity of K gene re- 
arrangement. It is yet to be clarified, however, whether 
the same PU.l site is responsible for regulating pro-B/ 
pre-B specificity and whether an additional site cooperates 
with the original E3’region in regulating the stage specific- 
ity. We believe that these transgenic studies, as well as 
the characterization of repressor proteins for recombina- 
tion, will give us new insight into the regulatory mecha- 
nisms of V,-J, joining. 
Experimental Procedures 
Plasmid Construction 
To construct the 3’-r substrate (Figure l), we subcloned the 7.0 kb 
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Hindlll-EcoRI fragment containing the germline Vhzlc gene segment 
(Heinrich et al., 1964) into the plasmid vector pBluescript KS(-) 
(Stratagene), yielding plasmid pMM221. The 15 kb EcoRl fragment 
of the J,-C, locus (Sakano et al., 1979) was then subcloned into the 
EcoRl site of pMM221, yielding pMM222 carrying the 3’-r construct. 
The 3’-d substrate, in which the region downstream of the Hpal site 
within C, (9.6 kb) was deleted from the 3’-r substrate, was constructed 
as follows, The 15 kb EcoRl J.-C, fragment was digested with Hpal, 
and the resulting 5.4 kb EcoRI-Hpal was then integrated between the 
EcoRl and Smal sites downstream of V r21c in pMM221 to yield the 3’-d. 
To generate the 3-x construct, we digested the 15 kb EcoRl J,-C, 
fragment with Xhol and inserted the resulting 14 kb EcoRI-Xhol frag- 
ment between the EcoRl and Smal sites downstream of Vxzlc in 
pMM221 by blunt-end ligation. 
To make the 3’-dE substrate, we ligated the 1.2 kb Xhol-EcoRI 
fragment of E3’to the 5.4 kb EcoRI-Hpal fragment containing the J,- 
C, locus by blunt-end ligation. We then inserted the resulting 6.6 kb 
EcoRl fragment into the EcoRl site of pMM221. 
To construct the dPU and dNF substrates, we deleted either the 
Ncol-ApaLI segment (126 bp) or the ApaLI-Xbal segment (270 bp) 
within the E3’ region as follows. The Hpal end of the 11 kb Sall-Hpal 
fragment isolated from pMM222 was changed to an Xhol site by adding 
an Xhol linker (8-mer). This fragment, containing V,,,, JK1 5, and a part 
of C,, was ligated to the 1.2 kb Xhol-Not1 fragment of E3’. The resulting 
13 kb Sall-Not1 fragment was then inserted between the Sall and Not1 
sites of pBluescript KS(+) (Stratagene), which had been modified to 
create an Ascl site in the polylinker sequence, yielding pBM16. To 
generate the dPU substrate, we deleted the 128 bp Ncol-ApaLI seg- 
ment from the 810 bp Xhol-Xbal fragment containing the 5’ half of 
E3’ with Ncol and ApaLl followed by blunt-end ligation. Similarly, to 
generate the dNF substrate, we deleted the 270 bp ApaLI-Xbal frag- 
ment from the 810 bp Xhol-Xbal fragment. The resulting fragment of 
either 650 bp or 540 bp was then ligated with the 440 bp Ascl-Xbal 
fragment containing the 3’ half of E3’. During this process, a 10 bp 
sequence was inserted downstream of the Xbal site within the E3’ 
region. To complete the construct, the Xhol-Ascl fragment, either 1 .l 
kb or 1.0 kb, was Inserted between the Xhol and Ascl sites of pBM16 
to yield the dPU substrate or the dNF substrate. 
To construct the PU.l -mutated substrate, mPU1, we first subcloned 
the 0.8 kb Ncol-EcoRI fragment of E3’ between the EcoRl and Ncol 
sites of pACYC184 (New England BioLabs), yielding pRH1. Next, we 
made a synthetic DNA for the 128 bp Ncol-ApaLI fragment in which 
the PU.l-binding sequence was changed from GAGGAA to TCTTCG 
and inserted it between the Ncol and ApaLl sitesof pRH1, The resulting 
0.8 kb Ncol-EcoRI fragment containing the mutated PU.l-binding se- 
quence was ligated first to the 0.4 kb Xhol(blunt)-Ncol fragment of the 
5’ part of E3’ and then to the 5.4 kb EcoRI-Hpal fragment containing 
the J,-C, locus. We then inserted the resulting 6.6 kb EcoRl fragment 
into the EcoRl site of pMM221 to yield the mPU1 substrate. 
Transgenic Mice 
For microinjection, the plasmid was drgested wrth Notl plus Sall or 
Ascl plus Sall, and the digested DNA was separated by agarose gel 
electrophoresis using 0.6% low-melhng agarose. The substrate DNA 
was purified by phenol-chroloform extraction. An aliquot of the DNA 
was microinjected into fertilized oocytes as described (Brinster et al., 
1985). Two independent founders were obtained for the 3-r construct, 
three for 3’.d, two for 3’-x, five for 3’-dE, four for dPU, three for dNF, 
and four for mPU1 (see Table 1). 
To determine the copy number of the transgene in each founder 
line, we digested kidney DNA from F1 transgenic mice with Sacl, sepa- 
rated it In an agarose gel, and carried out Southern blot hybridization 
with the 1.7 kb Sphl-Pstl fragment from pMM222 (J,l.i probe). The 
copy numberwas quantified by comparing the intensitesof hybridizing 
bands corresponding to the transgene (6.9 kb) and the endogenous 
gene (5.2 kb) by densitometric analysis using an lmagrng Analyzer 
(Molecular Dynamics) (see Table 1). 
Cell Sorting 
To separate B-lineage cells into n’ and u- subpopulations, we made 
srngle-cell suspensions from 6- to 14-week-old transgenic mouse bone 
marrow and placed them in cold phosphate-buffered saline (PBS) sup- 
plemented with 2% calf serum (HyClone) and 0.03% sodium azide 
Cells were washed with PBS and incubated with fluorescein isothiocya- 
nate (FITC)-conjugated anti-B220 (682, Coulter Clone) and biotiny- 
lated anti-p antibodies, Bet2 (Kung et al., 1981) (a gift from Dr. K. 
Takatsu, University of Tokyo), at a concentration of 0.1 mglml for 30 
min at 4°C. After washing, cells were incubated with streptavidin- 
phycoerythrin (0.02 mglml, Becton Dickinson) for 30 min at 4OC and 
then sorted with a FACS (FACStar, Becton Dickinson). 
To obtain purified B and T cells, we placed splenocytes in cold 
RPM1 1640 medium (Irvine Scientific) and washed them with PBS. 
Splenocytes were incubated with phycoerythrin-labeled anti-B220 and 
FITC-labeled anti-Thyl.2 antibodies for 30 min at 4OC and then sorted 
by FACS. Purified cells were determined to be >99% pure by FACS 
reanalysis. 
To classify B cells into six developmental stages, we prepared single 
cell suspensions from bone marrow and stained them as described 
previously (Hardy et al., 1991; Li et al., 1993). In brief, the prepro-B, 
early pro-B, and late pro-6 fractions were prepared by frrst staining 
bone marrow cells with a combination of fluoresceinS (antiCD43) 
phycoerythrin-BP-I, biotin-30Fl (anti-HSA). and allophycocyanin6B2 
(anti-B220) in staining medium, then washing and incubating with 
Texas red-avidin to reveal the avidin reagent. The pre-B, immature 
B, and mature B cell fractions were prepared by staining with fluores- 
ceinS7, phycoerythrin-331.12 (anti-IgM). biotin-AMS-15 (anti-IgD), 
and allophycocyanin6B2, followed by Texas red-avidin. Stained cells 
from five to ten transgenic mice were applied to a dual laser/dye laser 
flow cytometer (FACStar Plus, Becton Dickinson lmmunocytometry 
Systems, San Jose, CA) equipped with appropriate filters for four-color 
immunofluorescence, and 1 x IO’to 2 x 1O”cellsof selected fractions 
were sorted on ice Into microcentrifuge tubes. 
Detection of Rearrangement 
An aliquot (100 ng) of DNA was amplified by PCR in a reaction buffer 
(50 ul) of 50 mM KCI. 10 mM Tris-HCI (pH 8.0), 1.5 mM MgCI,. three 
different primers (each 1 PM), four kinds of deoxynucleotide triphos- 
phate (each 0.2 mM), and 1 U of Taq DNA polymerase (Perkin-Elmer 
Cetus). Each PCR cycle consisted of denaturation (1 min at 94%) 
annealing (1.5 min at 57%) and extension (2 min at 72OC). The cycle 
was repeated 21 times in a DNA Thermal Cycler (Perkin-Elmer Cetus). 
Aliquots of PCR products were separated in an agarose gel (1 .O%- 
1.4%) and analyzed by Southern blot hybridization using a VKz, probe 
(the 1.6 kb Bglll-Bglll fragment from pMM221) or a Jh,.5 probe (the 
1.7 kb Sphl-Pstl fragment from pMM222). PCR primers (Figure 1) 
used for the transgenic substrates were as follows. Vr2,., primer, 
5’.AGCCAGTGAAAGTGTTGATAG-3’; J,, primer, 5’.CTCACTGAA- 
GAGGAACAGAG-3’; JKs primer, 5’AGGTTGCCAGGAATGGCTCA-3’. 
For analysis of the endogenous K gene, we used the V,,< primer 
(5’-GACATTGGTAGTAGCTTAAAC-3’) and the Jb5 primer and carried 
out 28 cycles of amplification. 
For the analysis of K gene rearrangement at six different stages of 
6 cell development, we pelleted approximately 2 x lo5 sorted cells 
from each fraction, washed them in Tris-buffered saline (50 mM Tris, 
150 mM NaCl [pH 8.01) at 4%. and digested them with 0.5 mglml 
proteinase K for 2 hr at 5O“C in buffer A (0.5% sodium lauryl sarkosi- 
nate, 10 mM EDTA, 50 mM Tris [pH 8.01) containing 1% low meltrng 
point agarose. After digestion, samples were incubated on ice for 5 
min, dialyzed against three changes of TE buffer for a time period of 
6 hr to overnight each, and then stored at 4% Before use, DNA 
samples were melted at 67’C and diluted 1:20 with ddH,O. The DNA 
sample (10 ul) was used for PCR analysis in a reaction buffer (20 ml) 
of 10 mM Tris-HCI (pH 6.3) 10 mM KCI, 50 mM MgCI,. dNTPs (each 
0.2 mM), PCR primers (1 mM each), 0.5 U of Perfectmatch (Strata- 
gene), and 5.0 U of Taq DNA polymerase (Perkin-Elmer Cetus). Each 
cycle consisted of denaturation at 94’C for 1 min, annealing at 60°C 
for 1.5 min, and polymerization at 72°C for 5 min. Primers used were 
Vh2, 2 (5’-ATGCACTGGTACCAGCAGAAACC-3’) J,, , and Jh5. The PCR 
cycle was repeated 26-28 times. Aliquots of PCR products were sepa- 
rated in an agarose gel (1.0%-l .4%) and analyzed by Southern blot- 
ting with the J,, 5 probe as described above. 
Sequencing of V.-J. Junctions 
For DNA sequencing, PCR products were treated with T4 DNA poly- 
merase and digested with Asp718. Samples were then separated in 
a low melting point agarose gel (1 .00/o), and rearranged DNAfragments 
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were extracted from the gel. The V,-J. structures were subcloned 
into the Asp718-EcoRV sites of pBluescript SK(+) (Stratagene) and 
sequenced with Sequenase version 2.0 (United States Biochemical). 
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